Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and...
regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jul 15, 2022 8:05am
RE:RE:.018 per share pre-consolidation nice
Let's see what the preliminary short form prospectus will bring forth, if it does close on July 28, 2022? G1945V
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Jul 14, 2022 7:48pm
RE:.018 per share pre-consolidation nice
Sure has been, market isn't helping right now but it really didn't seem like they were ready to go public and overestimated peoples interest in the company. Feels like its at the bottom right
...more
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(18)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jul 13, 2022 5:07pm
.018 per share pre-consolidation nice
What a joke this company is, azzclowns running this POS.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 13, 2022 7:01am
New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Published in Nature Communications
Toronto, Ontario--(Newsfile Corp. - July 13, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 11, 2022 3:41pm
New Press Release - Satellos Bioscience Inc. Announces Proposed Offering of Units
Toronto, Ontario--(Newsfile Corp. - July 11, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed a preliminary...
read article.
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Jul 04, 2022 10:02am
Defeat Duchenne Canada
https://musculardystrophynews.com/2022/06/16/defeat-duchenne-canada-grants-1m-dmd-treatment-research/ Defeat Duchenne Canada grant recipients for this year include Michael Rudnicki, PhD, director of
...more
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Jul 04, 2022 9:44am
Patent
Satellos Co-founder and CSO, Dr. Michael Rudnicki, a co-inventor, noted, "this new patent application represents the culmination of two years of imaginative and detailed scientific effort led by
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 29, 2022 6:21pm
New Press Release - Satellos Bioscience Announces In-Licensing of New Patent Application
Toronto, Ontario--(Newsfile Corp. - June 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has licensed a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 22, 2022 7:01am
New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Officially Recognized as a Fellow of the Royal Society
Toronto, Ontario--(Newsfile Corp. - June 22, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...
read article.
(6)
•••
sovy888
X
View Profile
View Bullboard History
Comment by
sovy888
on Jun 21, 2022 8:40pm
RE:RE:Down again
you're absolutely right... this looks more and more like a big time loser
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 17, 2022 7:02am
New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Awarded Prestigious Defeat Duchenne Canada 2022 Grant
Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that Co-founder and Chief...
read article.
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Jun 16, 2022 6:36pm
RE:Down again
and again..investors just wanting out at this point.. kicking myself for not exiting when we had that last bump to 1.20. It really seems like satellos has nothing going on other than hopes and dreams.
...more
(18)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 14, 2022 7:15pm
Down again
Down .02 on volume guess we don't need your update Frankie boy! Waste of time and money Frankie boy hope you got lucky and shipfaced, least us shareholders could do for you. Lol
(18)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 10, 2022 6:31pm
LD Micro Invatational
Hey Frankie boy did you enjoy your paid vacation at your June 7 [ that was 3 days ago and we the shareholders have heard nothing? ] presentation? CAN HARDLY WAIT TO HEAR ALL THE GOOD
...more
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Jun 08, 2022 4:05pm
RE:.0325
absolutely brutal.. "nasdaq listing this year" laughable... don't worry I'm sure there will be some more big news about another conference they are going to.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up